… We evaluated S-specific T cell responses following one or two … ) after stimulation with WT
or Alpha S peptide pools in a subset of … Delta S peptide pools were analyzed in a subset of 86 …

To evaluate these risks, we enrolled 200 patient-facing HCWs between March 26 and April 8,
2020, in SARS-CoV-2 Acquisition in Frontline Healthcare Workers—Evaluation to inform …

Patients with cancer are at greater risk of severe COVID-19 and have been prioritised for
COVID-19 vaccination globally. We previously showed that following two doses of COVID-19 …

We sought to compare neutralising antibody responses between seronaive haemodialysis
patients and the healthy individuals we have already reported on as part of the Legacy study. …

… We thank S. Mao for his editorial input. This research was funded in part by the National …
AF has received funding from the European Union’s Horizon 2020 research and innovation …

… and we observed no correlation of S-reactive CD4 + T … S-reactive CD4 + T cell levels and
NAb titers against WT SARS-CoV-2 (Extended Data Fig. 5f). Finally, following stimulation with S …

… AF has received funding from the European Union’s Horizon 2020 research and innovation
program under Marie Skłodowska-Curie grant agreement 892360. STCS is supported and …

… UCLH provided access to barcoded swabs prebooked onto the Crick’s laboratory … the
speed of pipeline setup in the Crick’s central London research laboratory. All key documents are …

Most patients with blood cancer have reduced humoral and cellular immunity against SARS-CoV-2
variants following COVID-19 vaccination 1, 2, so are at increased risk of severe …

In this cohort study, we aim to compare outcomes from coronavirus disease 2019 (COVID-19)
in people with severe epilepsy and other co-morbidities living in long-term care facilities …